Look Up > Drugs > Flavoxate
Flavoxate
Pronunciation
U.S. Brand Names
Generic Available
Synonyms
Pharmacological Index
Use
Pregnancy Risk Factor
Contraindications
Warnings/Precautions
Adverse Reactions
Overdosage/Toxicology
Drug Interactions
Mechanism of Action
Pharmacodynamics/Kinetics
Usual Dosage
Dietary Considerations
Monitoring Parameters
Mental Health: Effects on Mental Status
Mental Health: Effects on Psychiatric Treatment
Dental Health: Local Anesthetic/Vasoconstrictor Precautions
Dental Health: Effects on Dental Treatment
Patient Information
Nursing Implications
Dosage Forms

Pronunciation
(fla VOKS ate)

U.S. Brand Names
Urispas®

Generic Available

No


Synonyms
Flavoxate Hydrochloride

Pharmacological Index

Antispasmodic Agent, Urinary


Use

Antispasmodic to provide symptomatic relief of dysuria, nocturia, suprapubic pain, urgency, and incontinence due to detrusor instability and hyper-reflexia in elderly with cystitis, urethritis, urethrocystitis, urethrotrigonitis, and prostatitis


Pregnancy Risk Factor

B


Contraindications

Pyloric or duodenal obstruction, GI hemorrhage, GI obstruction; ileus; achalasia; obstructive uropathies of lower urinary tract (BPH)


Warnings/Precautions

May cause drowsiness, vertigo, and ocular disturbances; administer cautiously in patients with suspected glaucoma


Adverse Reactions

>10%:

Central nervous system: Drowsiness

Gastrointestinal: Xerostomia, dry throat

1% to 10%:

Cardiovascular: Tachycardia, palpitations,

Central nervous system: Nervousness, fatigue, vertigo, headache, hyperpyrexia

Gastrointestinal: Constipation, nausea, vomiting

<1%: Confusion (especially in the elderly), rash, leukopenia, increased intraocular pressure


Overdosage/Toxicology

Symptoms of overdose include clumsiness, dizziness, drowsiness, flushing, hallucinations, irritability

Supportive care only


Drug Interactions

No data reported


Mechanism of Action

Synthetic antispasmotic with similar actions to that of propantheline; it exerts a direct relaxant effect on smooth muscles via phosphodiesterase inhibition, providing relief to a variety of smooth muscle spasms; it is especially useful for the treatment of bladder spasticity, whereby it produces an increase in urinary capacity


Pharmacodynamics/Kinetics

Onset of action: 55-60 minutes

Metabolism: To methyl; flavone carboxylic acid active

Elimination: 10% to 30% of dose excreted in urine within 6 hours


Usual Dosage

Children >12 years and Adults: Oral: 100-200 mg 3-4 times/day; reduce the dose when symptoms improve


Dietary Considerations

Should be administered with water on an empty stomach


Monitoring Parameters

Monitor I & O closely


Mental Health: Effects on Mental Status

Drowsiness is common; may cause nervousness


Mental Health: Effects on Psychiatric Treatment

None reported


Dental Health: Local Anesthetic/Vasoconstrictor Precautions

No information available to require special precautions


Dental Health: Effects on Dental Treatment

>10% of patients experience dry mouth


Patient Information

Take exactly as directed, with water, preferably on an empty stomach (1 hour before or 2 hours after meals). Do not use alcohol or OTC medications without consulting prescriber. You may experience mild drowsiness, nervousness, or dizziness (use caution when driving or engaging in tasks requiring alertness until response to drug is known); nausea, vomiting, dry mouth (small frequent meals, frequent oral care, chewing gum, or sucking hard candy may help); decreased ability to perspire (avoid extremes of heat); constipation (increased exercise or dietary fluid and fiber may help). Report vision changes (blurred vision); rapid heartbeat; or unresolved nausea, vomiting, or constipation. Breast-feeding precautions: Consult prescriber if breast-feeding.


Nursing Implications

Monitor I & O closely, incontinence, and PVR


Dosage Forms

Tablet, film coated, as hydrochloride: 100 mg


Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved